NCT04544878 (CLOVIS) is a clinical trial in Covid19, sponsored by Bicetre Hospital.

Who is sponsoring NCT04544878?

NCT04544878 is sponsored by Bicetre Hospital.

What condition does NCT04544878 study?

NCT04544878 studies Covid19, Pediatric ALL, Infection, Critical Illness, SARS-CoV Infection.

Is NCT04544878 still recruiting?

NCT04544878 is currently status unknown. Last updated 10 September 2020.

Last reviewed 2020-09-10 · How we verify

NCT04544878: CLOVIS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pediatric Intensive Care and COVID-19

Status unknown Last updated 10 September 2020

What this trial tests

trial in Covid19 in 100 participants. Status unknown.

Timeline

26 March 2020

Primary endpoint
1 June 2021

1 June 2021

Quick facts

Lead sponsor	Bicetre Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	26 March 2020
Primary completion	1 June 2021
Estimated completion	1 June 2021
Sites	1 location across France

Conditions studied

Covid19 — all drugs for Covid19 →
Pediatric ALL — all drugs for Pediatric ALL →
Infection — all drugs for Infection →
Critical Illness — all drugs for Critical Illness →

Sponsor

Bicetre Hospital

Who can join

Eligibility, any sex, with Covid19 or Pediatric ALL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this prospective longitudinal cohort the investigators reported the clinical, and biological characteristics of all critically ill patients admitted in the pediatric intensive care unit (PICU) of Bicêtre Hospital during the 2019 coronavirus disease (COVID-19) pandemics. Patients were older than 37 weeks of gestational age. No upper limit was set as the unit was transiently converted into a pediatric "adult COVID-19" intensive care unit.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Anakinra in pediatric acute fulminant myocarditis.
Maunier L, Charbel R, Lambert V, Tissières P, et al · · 2022 · cited 16× · PMID 36018450 · DOI 10.1186/s13613-022-01054-0
Myeloid phenotypes in severe COVID-19 predict secondary infection and mortality: a pilot study.
Marais C, Claude C, Semaan N, Charbel R, et al · · 2021 · cited 15× · PMID 34259942 · DOI 10.1186/s13613-021-00896-4

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Bicetre Hospital trials

Trials by the same sponsor.

NCT07453901 — The Multicentre Prospective Observational Study on the Management of Septic Shock · not yet recruiting
NCT06772038 — Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion · recruiting
NCT06839404 — Pharmacodynamic Analysis of the HaemOdynamic Effects of a Standard Fluid BolUS · recruiting
NCT05676723 — Thoracic Fluid Content by Bioimpedance-based Starling System · completed
NCT04870892 — Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04544878 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bicetre Hospital
Last refreshed: 10 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04544878.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing